Stanford Home
Ovarian Kaleidoscope Database (OKdb)

Home

History

Transgenic Mouse Models

INFORGRAPHICS

Search
Submit
Update
Chroms
Browse
Admin

Hsueh lab

HPMR

Visits
since 01/2001:
176557

Fas OKDB#: 299
 Symbols: TNFRSF6 Species: human
 Synonyms: APOPTOSIS ANTIGEN 1, APT1| FAS ANTIGEN| SURFACE ANTIGEN APO1, APO1| CD95|  Locus: 10q24.1 in Homo sapiens
HPMR


For retrieval of Nucleotide and Amino Acid sequences please go to: OMIM Entrez Gene
Mammalian Reproductive Genetics   Endometrium Database Resource   Orthologous Genes   UCSC Genome Browser   GEO Profiles new!   Amazonia (transcriptome data) new!

R-L INTERACTIONS   MGI

DNA Microarrays
SHOW DATA ...
link to BioGPS
General Comment The Fas antigen is a cell surface receptor that triggers apoptosis when bound to Fas ligand (FasL)Atresia found in early antral rat follicles positive for Fas and FasL, however, atresia and granulosa cell apoptosis noted in large antral and preovulatory follicles showed Fas, but not FasL (Kim et al.,1999). IFN increases Fas antigen expression (Quirk et al.,1997) Coculturing IFN-pretreated granulosa cells with zona-free oocytes induced granulosa cell apoptosis (Hakuno et al.,1996). Structural homology of Fas with TNF and low-affinity nerve growth factor receptor. Murine granulosa cells resistant to Fas-mediated apoptosis, but when co-treated with TNF and IFN or CX, apoptosis resulted. Note that human TNF did not repeat these results (Quirk et al.,1998).

NCBI Summary: The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contains a death domain. It has been shown to play a central role in the physiological regulation of programmed cell death, and has been implicated in the pathogenesis of various malignancies and diseases of the immune system. The interaction of this receptor with its ligand allows the formation of a death-inducing signaling complex that includes Fas-associated death domain protein (FADD), caspase 8, and caspase 10. The autoproteolytic processing of the caspases in the complex triggers a downstream caspase cascade, and leads to apoptosis. This receptor has been also shown to activate NF-kappaB, MAPK3/ERK1, and MAPK8/JNK, and is found to be involved in transducing the proliferating signals in normal diploid fibroblast and T cells. At least eight alternatively spliced transcript variants encoding seven distinct isoforms have been described. The isoforms lacking the transmembrane domain may negatively regulate the apoptosis mediated by the full length isoform.
General function Receptor, Cell death/survival, Apoptosis
Comment Fas is a cell surface receptor that, when engaged by Fas ligand or specific agonistic antibodies, triggers apoptosis (Quirk et al.,1997). Colocalization of Fas and Fas ligand in certain follicles intimately correlated with granulosa cell apoptosis; no Fas or FasL found in healthy follicles (Hakuno et al.,1996).
Cellular localization Plasma membrane
Comment Surface epithelial cells died in response Fas mAb (Quirk et al.,1997).
Ovarian function Follicle atresia, Luteolysis
Comment A time-course study by Mori et al. (1997) showed that Fas mRNA was positive in murine atretic follicles through day 0 and day 2 of PMSG stimulation and negative thereafter. Follicular atresia shown to be caused by apoptosis, and apoptosis associated with internucleosomal DNA fragmentation directly regulated by the Fas/FasL system (Mori et al.,1997). Abundant expression of Fas antigen in the regressing corpora lutea and atretic follicles suggests that the Fas antigen participates in luteal regression and follicular atresia through the apoptotic process. Expression of Fas in oocyte of primordial and primary follicles, followed by decrease in the Fas expression in the oocyte with the advance of follicular maturation suggests that the Fas antigen expression in the oocyte may play a role in follicular selection (Kondo et al., 1996).
Expression regulated by FSH, LH
Comment Addition of gonadotropins led to Fas, FasL, and p53 decrease and subsequent follicular growth; also, Fas and FasL found in granulosa cells of atretic follicles localized with apoptosis pattern induced by gonadotropin withdrawal (Kim et al.,1999). Fas antigen mRNA was detectable in cultured bovine granulosa and theca cells, and expression was increased by treatment with interferon-gamma but not tumor necrosis factor-alpha. Granulosa and theca cells were resistant to Fas-induced killing unless pretreated with interferon-gamma. Tumor necrosis factor-alpha had no effect on Fas-induced killing (Vickers et al., 2000).
Ovarian localization Oocyte, Granulosa, Theca, Luteal cells
Comment Fas/FasL system found to activate sphingomyelin-ceramide pathway in thecal/interstitial cells (Foghi et al.,1998). Cataldo NA, et al 2000 reported immunolocalization of Fas and Fas ligand in the ovaries of women with polycystic ovary syndrome relationship to apoptosis. Fas immunostaining was present in pre-antral follicle oocytes, some primary and secondary pre-antral follicle granulosa cells, and both granulosa and theca of antral follicles, Thecal staining persisted with advancing atresia, while granulosa staining declined, In antral follicles, abundant Fas-positive cells co-localized with scattered nuclei immunopositive for apoptosis. Ovarian vascular myocytes were strongly Fas-immunopositive. Fas-ligand immunostaining was present in pre-antral follicles in oocytes and variably in granulosa, In antral follicles, granulosa and thecal Fas ligand staining increased with advancing atresia, Normal control ovaries showed follicular Fas and Fas ligand staining patterns similar to those in PCOS, but vascular staining was less prominent. In one healthy follicle, Fas immunostaining was seen in the oocyte and weakly in mural granulosa and theca interna.
Follicle stages Primordial, Primary, Secondary, Antral, Corpus luteum
Comment Fas antigen staining in secondary and antral follicles showed stains only for the oocyte, while in preovulatory follicles, neither the oocyte nor the granulosa and theca cells were stained for the Fas antigen. In corpora lutea, Fas antigen staining became apparent in the granulosa lutein cells during early luteal phase and intensified during mid luteal phase, while the theca lutein cells became positive for the Fas antigen staining during the mid luteal phase. During the late luteal phase, the staining intensity of the Fas antigen in the regressing corpora lutea further increased. In atretic primordial and primary follicles, only degenerating oocyte showed the Fas antigen staining. By contrast, in atretic antral follicles, the Fas antigen staining was profound in the degenerating granulosa cells at the early stage of atresia, and at the mid stage of atresia it was intensified in the cell surface of the scattered granulosa cells and became apparent in the theca cells. At late stage of atresia Fas antigen remained only in hypertrophied theca cells (Kondo et al.,1996). However, Sakamaki et al.(1997) found Fas protein in granulosa and luteal cells but not on oocytes in ovary. Binding of FasL to Fas receptor linked to apoptosis during regression of CL (Roughton et al.,1999).Pru JK, et al 202 investigated soluble Fasl, (sFasL)-activated production of ceramide, a second messenger of the sphingomyelin pathway, and activation of p38(MAPK), a member of the MAPK family. sFasL activated the sphingomyelin pathway, as evidenced by a 2-fold increase (P < 0.05) in the production of ceramide. Pretreatment with imipramine (50 mum), an inhibitor of acid sphingomyelinase activity, attenuated (75%; P < 0.05) sFasL-induced ceramide production, suggesting that the increase in ceramide was par- tially the result of acid sphingomyelinase-mediated hydrolysis of sphingomyelin. Treatment of luteal cells with sFasL or a cell-permeable ceramide analog (C8) for 24-48 h resulted in a significant increase (P < 0.05) in apoptosis. Western blot analysis revealed that sFasL had little effect on the activation of p38(MAPK) in primary bovine luteal steroidogenic cells. Furthermore, pretreatment with the p38(MAPK) inhibitor SB203590 failed (P > 0.05) to inhibit sFasL- or C8-induced death. Although sFasL did not alter basal progesterone levels detected in the culture medium, C8 caused a significant increase (P < 0.05) in progesterone concentrations within the medium. Collectively, these data suggest that the role of FasL, in luteolysis may be to activate the stress-induced sphingomyelin pathway that, in turn, serves as a mediator of apoptosis.
Phenotypes
Mutations 5 mutations

Species: human
Mutation name: None
type: None
fertility: None
Comment: Jackson et al.(1999) 12 (71%) of the 17 unique APT1 mutations in unrelated ALPS probands occurred in exons 7 to 9, which encode the intracellular portion of FAS. In vitro, activated lymphocytes showed apoptotic defects when exposed to an anti-FAS agonist monoclonal antibody. Similar defects were found in a FAS-negative cell line transfected with cDNAs bearing each of the mutations. In cotransfection experiments, FAS constructs with either intra- or extracellular mutations caused dominant inhibition of apoptosis mediated by wildtype FAS. Among the ALPS-associated FAS mutants, dominant inhibition of apoptosis was much more pronounced in mutants affecting the intracellular, versus extracellular, portion of the FAS receptor. Mutations causing disruption of the intracellular FAS death domain also showed a higher penetrance of ALPS phenotype features in mutation-bearing relatives. Significant ALPS-related morbidity occurred in 44% of relatives with intracellular mutations, versus 0% of relatives with extracellular mutations. Thus, the location of mutations within APT1 strongly influences the development and the severity of ALPS.

Species: human
Mutation name: ALPS
type: naturally occurring
fertility: None
Comment: Fisher et al. (1995) described 5 unrelated children with a rare autoimmune lymphoproliferative syndrome (ALPS) characterized by massive nonmalignant lymphadenopathy, autoimmune phenomena, and expanded populations of TCR-CD3(+)CD4(-)CD8(-) lymphocytes. These findings, suggesting a genetic defect in the ability of T lymphocytes to respond to normal immunoregulatory mechanisms, prompted evaluation of lymphocyte apoptosis. Each child had defective FAS-mediated T lymphocyte apoptosis associated with a unique, deleterious FAS gene mutation. One mutation appeared to cause a simple loss of function; however, 4 others had a dominant-negative phenotype when coexpressed with normal FAS. Patients have one mutated and one normal allele, ruling out a recessive mutation. From 11 families with ALPS, Vaishnaw et al.(1999) studied 8 patients to define mechanisms responsible for defective CD95-mediated apoptosis. Mutations in and around the death domain of CD95 had a dominant-negative effect explained by interference with the recruitment of the signal adaptor protein FADD to the death domain. Intracellular domain (ICD) mutations were associated with a highly penetrant Canale-Smith syndrome phenotype and an autosomal dominant inheritance pattern. In contrast, mutations affecting CD95 extracellular domain (ECD) resulted in failure of extracellular expression of mutant protein or impaired binding to CD95 ligand. These mutations did not have a dominant-negative effect. Martin et al.(1999) showed that local or global alterations in the structure of the cytoplasmic death domain from 9 independent ALPS CD95 death-domain mutations resulted in a failure to bind the FADD/MORT1 signaling protein. Despite heterozygosity for the abnormal allele, lymphocytes from ALPS patients showed markedly decreased FADD association and a loss of caspase recruitment and activation after CD95 crosslinking. These data suggested that intracytoplasmic CD95 mutations in ALPS impair apoptosis chiefly by disrupting death-domain interactions with the signaling protein FADD/MORT1.

Species: human
Mutation name: TEN
type: naturally occurring
fertility: None
Comment: Viard et al. (1998) detected high levels of soluble Fas ligand in sera of patients with toxic epidermal necrolysis (TEN). Keratinocytes of TEN patients produced FasL, which induced keratinic apoptosis. Incubating keratinocytes with intravenous immunoglobulin (IVIG) completely inhibited Fas-mediated keratinocyte apoptosis. A naturally occurring anti-Fas immunoglobulin present in IVIG blocks the Fas receptor and mediates this response.

Species: mouse
Mutation name: gld
type: naturally occurring
fertility: None
Comment: Mutated CD95 and CD95L genes (Sneller et al.,1992)$ A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. Sneller MC et al. In mice, the two distinct autosomal recessive genes lpr and gld can induce a syndrome characterized by autoantibody formation and the progressive accumulation of an unusual CD4-CD8- T cell population in peripheral lymphoid tissue. This phenotype does not precisely mirror any human disease. In this report we describe two patients with a progressive lymphoproliferative disorder associated with autoimmunity. The peripheral blood and lymph nodes of these patients contained large numbers of an unusual CD4-CD8- T cell population. These CD4-CD8- T cells express surface markers characteristic of mature peripheral blood T cells (CD3, CD2, CD5), express the alpha/beta form of the T cell receptor, and do not express surface markers characteristic of immature thymocytes (CD1) or NK cells (CD16, CD56). Functionally, these cells exhibited deficient proliferation and lymphokine production upon stimulation with mitogenic antibodies to CD3 or CD2. Both proliferation and lymphokine production could be augmented by co-stimulation with an antibody directed at the CD28 determinant. The clinical and immunological features of this syndrome resemble the lymphoproliferative/autoimmune disease seen in lpr and gld mice.. Oocyte growth and follicular development in KIT-deficient Fas-knockout mice. Moniruzzaman M et al. In mammals, oocyte growth and follicular development are known to be regulated by KIT, a tyrosine kinase receptor. Fas is a member of the death receptor family inducing apoptosis. Here, we investigated germ cell survival, oocyte growth and follicular development in KIT-deficient (W(v)/W(v):Fas(+/+)), Fas-deficient (+/+:Fas(-/-)), and both KIT- and Fas-deficient (W(v)/W(v):Fas(-/-)) mice during fetal and postnatal periods. Further, the ovaries of these mice were transplanted in immunodeficient mice to compare oocyte growth and follicular development under a condition isolated from the extraovarian effects of KIT- and Fas-deficiency. Higher numbers of germ cells were found in the fetal and postnatal ovaries of Fas-deficient mice than in the same-aged wild-type mice. In KIT-deficient mice, ovaries at 13 days postcoitum (dpc) contained 1106+/-72 (n=3) germ cells, but the ovaries contained no oocytes after birth. Twenty-one days after transplantation of the ovaries at 13 dpc, no oocytes/germ cells were found. A higher number of germ cells (3843+/-108; n=3) were observed in the W(v)/W(v):Fas(-/-) genotypes than in W(v)/W(v):Fas(+/+) mice at 13 dpc. Furthermore, W(v)/W(v):Fas(-/-) mice contained 528+/-91 (n=3) oocytes at 2 days, and follicles developed to the antral stage at 14 days of age. After transplantation of fetal and neonatal ovaries from W(v)/W(v):Fas(-/-) mice, increased numbers of growing oocytes and developing follicles were obtained compared with those in 14-day old ovaries in vivo. These results show that oocytes grow and follicles develop without KIT signaling, although KIT might be essential for the survival of germ cells/oocytes in mice.

Species: mouse
Mutation name: lpr
type: naturally occurring
fertility: subfertile
Comment: MRL/MpJ-Fas(lpr) mice show abnormalities in ovarian function and morphology with the progression of autoimmune disease. Otani Y et al. (2015) The immune system is known to affect reproductive function, and maternal-fetal immune tolerance is essential for a successful pregnancy. To investigate the relationship between autoimmune disease and female reproductive function, we performed a comparative analysis of the ovarian phenotypes for C57BL/6 mice, autoimmune disease-prone MRL/MpJ (MRL/+) mice and congenic MRL/MpJ-Fas(lpr) (MRL/lpr) mice harboring a mutation in the Fas gene that speeds disease onset. Both MRL-background strains showed earlier vaginal opening than C57BL/6 mice. The estrous cycle became irregular by 6 and 12 months of age in MRL/lpr mice and mice of the other two strains, respectively. Histological analysis at 3 months revealed that the number of primordial follicles was smaller in MRL-background mice than in C57BL/6 mice after 3 months. In addition, MRL/lpr and MRL/+ mice displayed lower numbers of ovarian follicles and corpora lutea at 3 and 6 months, and 6 and 12 months, respectively, than that in age-matched C57BL/6 mice. MRL/lpr and MRL/+ mice developed ovarian interstitial glands after 3 and 6 months, respectively. In particular, MRL/lpr mice showed numerous infiltrating lymphocytes within the ovarian interstitia, and partially stratified ovarian surface epithelia with more developed microvilli than that observed in C57BL/6 mice at 6 months. No significant differences in serum hormone levels were observed between the strains. In conclusion, MRL/lpr mice display altered ovarian development, morphology and function consistent with the progression of severe autoimmune disease, as these findings are less severe in MRL/+ counterparts.////////////////// Lymphoproliferation (lpr) mutation shows defects in the Fas antigen gene; mice develop lymphadenopathy and suffer from a systemic lupus erythematosus-like autoimmune disease, indicating an important role for Fas antigen in the negative selection of autoreactive T cells in the thymus. The point mutation in the Fas gene in the lpr mouse was a T-to-A transversion causing the substitution of asparagine for isoleucine (Watanabe-Fukunaga et al.,1992). Peripheral activated T cells from lpr/lpr mutant mice that express a reduced number of APO1 receptors have a defect in T-cell receptor (TCR)-induced apoptosis. Recessive mutation (Fisher et al.,1995).

Genomic Region show genomic region
Phenotypes and GWAS show phenotypes and GWAS
Links
OMIM (Online Mendelian Inheritance in Man: an excellent source of general gene description and genetic information.)
OMIM \ Animal Model
KEGG Pathways
Recent Publications
None
Search for Antibody


created: Dec. 3, 1999, midnight by: Garnier   email:
home page:
last update: April 15, 2015, 10:38 a.m. by: hsueh    email:



Use the back button of your browser to return to the Gene List.

Click here to return to gene search form